한국어
English
日本語
中文(简体)
Bosevi Tablets
100mg
Tablet · Prescription medication · Combination
Gilead Sciences Korea Co., Ltd.
Bociplavir is an antiviral ingredient used for the treatment of chronic hepatitis C.
MFDS ingredient code M282286
Bociplavir is an antiviral ingredient used in the treatment of chronic hepatitis C virus (HCV) infection. This ingredient works by inhibiting the replication process of the virus, thereby preventing the spread of the infection. It is primarily used in combination with other antiviral agents to enhance therapeutic efficacy.
Bociplavir impedes the replication of the virus by blocking the activity of specific proteins within the HCV virus. This helps to reduce the viral load and prevent liver damage. As the replication process halts, the infection gradually improves.
Approved uses differ by product. Check each product's information for its actual use.
Bociplavir is an NS3/4A protease inhibitor of HCV, which directly blocks viral protein degradation, unlike other antiviral agents. This allows it to be effective against resistant viruses, making it suitable for combination therapy.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.